CT-011 MAb in DLBCL Patients Following ASCT

Clinical trial NCT00532259 · COMPLETED

Trial details

NCT number: NCT00532259
Sponsor: CureTech Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large Cell, Diffuse Lymphoma, Mixed Cell, Diffuse Primary Mediastinal Large B-Cell Lymphoma

Start date: 2007-10-01
Primary completion: 2011-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.